Raphael Mechoulam
Impact in
- Pharmacology top 0.01%
- Cannabis and Cannabinoid Research
- Toxicology top 0.01%
- Forensic Toxicology and Drug Analysis
Papers in
- Pharmacology 348
- Cannabis and Cannabinoid Research 338
-
- Neuroscience and Neuropharmacology Research 65
- Neurotransmitter Receptor Influence on Behavior 59
- Co-authors
- Yehiel Gaoni (16 shared papers)Roger G. Pertwee (27 shared papers)Aviva Breuer (35 shared papers)Ester Fride (30 shared papers)Linda A. Parker (29 shared papers)Vincenzo Di Marzo (28 shared papers)Graeme Griffin (3 shared papers)Esther Shohami (31 shared papers)
- Journals
- Journal of the American Chemical Society (18 papers)Journal of Medicinal Chemistry (16 papers)European Journal of Pharmacology (16 papers)Psychopharmacology (15 papers)British Journal of Pharmacology (14 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Raphael Mechoulam
444 papers receiving 44.5k citations
Raphael Mechoulam's Hit Papers
Peers
Comparison fields: 5 of 178
- Pharmacology 38.7k
- Toxicology 4.3k
- Cellular and Molecular Neuroscience 16.4k
- Endocrine and Autonomic Systems 3.7k
- Biological Psychiatry 823
Countries citing papers authored by Raphael Mechoulam
This map shows the geographic impact of Raphael Mechoulam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Mechoulam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Mechoulam more than expected).
Fields of papers citing papers by Raphael Mechoulam
This network shows the impact of papers produced by Raphael Mechoulam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Mechoulam. The network helps show where Raphael Mechoulam may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Mechoulam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 450 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor Hit paper breakdown → | 1992 | 4758 |
| 2 | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Hit paper breakdown → | 1995 | 2449 |
| 3 | Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish Hit paper breakdown → | 1964 | 1923 |
| 4 | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 Hit paper breakdown → | 2010 | 1370 |
| 5 | Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Hit paper breakdown → | 2001 | 1107 |
| 6 | The Endocannabinoid System and the Brain Hit paper breakdown → | 2012 | 809 |
| 7 | Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb Hit paper breakdown → | 2009 | 676 |
| 8 | 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor Hit paper breakdown → | 2001 | 643 |
| 9 | An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Hit paper breakdown → | 2001 | 642 |
| 10 | The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Hit paper breakdown → | 2000 | 567 |
| 11 | Endocannabinoid signaling at the periphery: 50 years after THC Hit paper breakdown → | 2015 | 531 |
| 12 | An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Hit paper breakdown → | 1998 | 525 |
| 13 | 1999 | 494 | |
| 14 | 2006 | 457 | |
| 15 | Marihuana Chemistry Hit paper breakdown → | 1970 | 440 |
| 16 | Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy Hit paper breakdown → | 2010 | 430 |
| 17 | 2007 | 429 | |
| 18 | 2002 | 414 | |
| 19 | 1993 | 407 | |
| 20 | Hashish—I Hit paper breakdown → | 1963 | 397 |
About Raphael Mechoulam
Raphael Mechoulam is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Molecular Biology, Plant Science and Endocrinology, Diabetes and Metabolism, having authored 450 papers that have together received 46.6k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (338 papers), Neuroscience and Neuropharmacology Research (65 papers), Neurotransmitter Receptor Influence on Behavior (59 papers), GABA and Rice Research (49 papers), Sleep and Wakefulness Research (45 papers), Diet, Metabolism, and Disease (43 papers), Forensic Toxicology and Drug Analysis (39 papers) and Alcohol Consumption and Health Effects (33 papers). The work is most often cited by research in Pharmacology (38.7k citations), Toxicology (4.3k citations), Cellular and Molecular Neuroscience (16.4k citations), Endocrine and Autonomic Systems (3.7k citations) and Biological Psychiatry (823 citations). Raphael Mechoulam has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Yehiel Gaoni, Roger G. Pertwee, Aviva Breuer, Ester Fride, Linda A. Parker, Vincenzo Di Marzo, Graeme Griffin, Esther Shohami, William A. Devane and Ruth Gallily. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry, European Journal of Pharmacology, Psychopharmacology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.